Investitionen in die Gesundheit und Bildung könnten die negativen Folgen des demographischen Wandels und der Globalisierung durch eine Erhöhung der Altersgrenze bis 2050 auf 70 Jahre mildern. Damit soll keine bestimmte gesetzliche Altersgrenze begründet oder gar fixiert werden. Eine Erhöhung...

Rising costs in pharmaceutical expenditure have become a major concern for policy makers in Germany over the last years. Therefore the pharmaceutical market in Germany has been increasingly targeted by different kinds of regulations, focussing both on the supply and the demand side, using price,...

This chapter illustrates the contribution which could be made to realising the Lisbon Strategy of the European Union for growth and jobs by innovative healthcare policy favouring a preventive orientation of healthcare. The prevention and control of risk factors for chronic diseases, as well as...